Agents for prevention or treatment of chronic rheumatism and sepsis

The pharmaceutical use of 1-cinnamoyl-2-pyrrolidinone derivatives having the activities to inhibit the production of IL-1 beta and the release of TNF alpha . Those derivatives are useful in the treatment or prophylaxis of the diseases such as chronic rheumatism and sepsis.

Saved in:
Bibliographic Details
Main Authors SAITO, YUKIO, HATANAKA, SHIGEO, ARIGA, MASATO, MOMOSE, KENICHI, KATSUYAMA, KOICHI
Format Patent
LanguageEnglish
French
German
Published 01.04.1998
Edition6
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The pharmaceutical use of 1-cinnamoyl-2-pyrrolidinone derivatives having the activities to inhibit the production of IL-1 beta and the release of TNF alpha . Those derivatives are useful in the treatment or prophylaxis of the diseases such as chronic rheumatism and sepsis.
Bibliography:Application Number: EP19950120407